Anya E.R. Prince
机构: Professor University of Iowa College of Law
每年引用次数
引用次数
引用: 1,334
H-指数: 19
I10-指数 : 32
出版物: 70
Insurance Risk Classification in an Era of Genomics: Is a Rational Discrimination Policy Rational?
Anya E R Prince
Nebraska law review 96 ( 3) 624 -687
4
2017
Potential (mis)use of epigenetic age estimators by private companies and public agencies: human rights law should provide ethical guidance
Charles Dupras , Yann Joly , Mark A Rothstein , Anya E R Prince
Environmental Epigenetics 5 ( 3)
3
2019
Age and Perceived Risks and Benefits of Preventive Genomic Screening
Margaret Waltz , R Jean Cadigan , Anya E R Prince , Debra Skinner
Genetics in Medicine 20 ( 9) 1038 -1044
5
2018
What guidance does HIPAA offer to providers considering familial risk notification and cascade genetic testing
Nora B Henrikson , Jennifer K Wagner , Heather Hampel , Christopher DeVore
Journal of Law and the Biosciences 7 ( 1)
2020
Political economy, stakeholder voices, and saliency: lessons from international policies regulating insurer use of genetic information.
Anya E R Prince
Journal of Law and the Biosciences 5 ( 3) 461 -494
5
2018
Automatic Placement of Genomic Research Results in Medical Records: Do Researchers Have a Duty? Should Participants Have a Choice?
R. Jean Cadigan , John M. Conley , Arlene M. Davis , Anya E.R. Prince
Journal of Law Medicine & Ethics 43 ( 4) 827 -842
8
2015
Comprehensive Protection of Genetic Information: One Size Privacy or Property Models May Not Fit All
Anya E.R. Prince
Brooklyn law review 79 ( 1) 4
5
2013
The Problems with Patchwork: State Approaches to Regulating Insurer Use of Genetic Information
Anya E.R. Prince , Anna C.F. Lewis , Jarrod O. Anderson
DePaul journal of health care law 22 ( 1) 1
2021
Comparative perspectives: regulating insurer use of genetic information
Anya E.R. Prince
European Journal of Human Genetics 27 ( 3) 340 -348
6
2019
Genomic Screening of the General Adult Population: Key Concepts for Assessing Net Benefit with Systematic Evidence Reviews
Anya E.R. Prince , Jonathan S. Berg , James P. Evans , Daniel E. Jonas
Genetics in Medicine 17 ( 6) 441 -443
13
2015
Shared decision-making in vascular surgery.
Jun Xu , Anya E.R. Prince
Journal of Vascular Surgery 70 ( 5) 1711 -1715
1
2019
Which Results to Return: Subjective Judgments in Selecting Medically Actionable Genes.
Gabriel Lázaro-Muñoz , John M. Conley , Arlene M. Davis , Anya E.R. Prince
Genetic Testing and Molecular Biomarkers 21 ( 3) 184 -194
12
2017
Prevention for those who can pay: insurance reimbursement of genetic-based preventive interventions in the liminal state between health and disease
Anya E.R. Prince
Journal of Law and the Biosciences 2 ( 2) 365 -395
29
2015
Response to peer commentaries: prevention for those who can pay.
Anya E.R. Prince
Journal of Law and the Biosciences 3 ( 1) 202 -205
2016
Is Real-Time ELSI Realistic?
John M. Conley , Anya E.R Prince , Arlene M. Davis , Jean Cadigan
AJOB empirical bioethics 11 ( 2) 134 -144
2020
Addressing underrepresentation in genomics research through community engagement
Amy A Lemke , Edward D Esplin , Aaron J Goldenberg , Claudia Gonzaga-Jauregui
The American Journal of Human Genetics 109 ( 9) 1563 -1571
8
2022
Reconceptualizing harms and benefits in the genomic age.
Anya ER Prince , Benjamin E Berkman
Personalized Medicine 15 ( 5) 419 -428
4
2018
Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium.
Joon-Ho Yu , Paul S Appelbaum , Kyle B Brothers , Steven Joffe
Personalized Medicine 16 ( 4) 325 -333
5
2019
Anti-selection \& Genetic Testing in Insurance: An Interdisciplinary Perspective
Dexter Golinghorst , Aisling De Paor , Yann Joly , Angus S Macdonald
Journal of Law, Medicine \& Ethics 50 ( 1) 139 -154
5
2022
Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization
Anna CF Lewis , Emma F Perez , Anya ER Prince , Hana R Flaxman
Genome Medicine 14 ( 1) 114 -114
35
2022